(photo credit: Avi Hayoun)
Most people know of colleagues at work – or themselves – who have taken sick
days due to acute back pain. But chronic back and joint pains have now been
shown to cause half of all work absences over three days or more, according to
an international study conducted in 25 countries and last year also in Israel.
Musculoskeletal disorders (MSDs) – a general name for a wide variety of
orthopedic and rheumatological conditions such as back pain, strained hands or
neck and joint diseases – affect 700,000 Israelis (1 in 10) and annually cost
the economy some NIS 26 billion or 4 percent of the gross national
RELATED:Healthcare: US can learn from IsraelKnesset panel: National plan needed for healthcare system
According to the World Health Organization, these disorders are
classified as fourth among the 10 most common diseases affecting women and ninth
among those affecting men. They are accompanied by pains and many disabilities
that may further affect functional aspects of individuals in both their work and
personal life. The study estimates that the number of individuals suffering from
MSDs is expected to rise considerably and damage the Israeli workforce
production and industrial capacity, while intensifying the burden on both health
care and welfare systems.
Prof. Joseph Ribak, chairman of the Health
Ministry’s national council for workers health, said that 80% of adults will be
affected by MSDs at some point in their lives. “The new study demonstrates how
serious the problem is and that it requires systemic treatment. Resources must
be allocated for early diagnosis and treatment.
Changing the current
perception from a rehabilitative model to a preventative model would allow for
the preservation of thousands of working places while saving substantial public
funds,” he said.
The “Fit For Work?” project was conducted by England’s
The Work Foundation as part of a unique research program comprising 25 European
and other countries. The project was conducted here in collaboration with the
government and other local bodies, examining in detail how MSDs impact the life
and employment potential of thousands of Israeli workers. The results were
revealed during a recent Health Economy Forum convened specially to discuss the
ramifications on the labor market, the health care system and the
Prof. Moshe Tishler, chairman of Israel Rheumatology Society,
said that many patients suffering from MSDs are oblivious to the future
implications of their disease or are referred to a specialist too late. “This
has direct impact on the severity of their disorder and chances for recovery.
These circumstances necessitate systemic emergency treatment,” adds
Data provided by the National Insurance Institute shows that
32,612 Israelis, mostly at working age, are receiving government disability
pensions due to MSDs. Rehabilitation efforts invested in such people are
considerably more expensive than those aimed at other disorders, yet only 35% of
rehabilitated persons return to the workforce. Moreover, MSDs are the most
common cause for early retirement due to health reasons and affect not only
those suffering from them, but also heavily burden the economy.
research conclusion was that the number of MSD patients in the Israeli workforce
is expected to rise in upcoming decades, and its impact on the economy will
continue to escalate. The Work Foundation’s general manager, Steven Bevan, added
that “evidence presented by the report shows that many Israelis at workingage
are directly affected by MSDs or will be affected by them in the next few years.
This will have substantial economic and social ramifications, reducing Israeli
workforce production capacity in general as well as industrial capacity, while
intensifying the burden on both health care and pension systems.”
people with MSDs return to the labor market, or better yet, not be released from
it to begin with? Not only can they do it – but they must, said Bevan. “The
prevalent approach in Israel presumes that one has to achieve 100% fitness to
return to work. The study refutes this approach, contending that if family
doctors had been required to supply a ‘fitness certificate’ (indicating how
employees are still able to perform) rather than an ‘illness certificate,’
employers would see more clearly what affected employees can still do at work.
This approach is put into use in Britain, and its introduction to Israel should
also be considered.”
This approach, by which a patient’s position is to
be preserved even during rehabilitation – rather than at its end – intrinsically
differs from Israel’s current model guiding rehabilitation and return to work.
This perception means that the patient’s employment should be preserved during
the rehabilitation process as well.
The new study demonstrates how
serious and immediate the problem is, Ribak concluded.
requires systemic treatment. As I have argued before, it’s the employers’
commitment to provide a healthy work environment and discover problems of their
employees at an early stage. This may require legislation, preventive medical
treatments, ergonomic level adjustment and an annual health survey for early
detection of these disorders. In my opinion, employers should be compelled to
conduct such a survey, as they are forced to install smoke detectors or insure
Most of the recommendations are aimed at the state,
which is required to systematically and comprehensively address the problem
rather than its symptoms, adopting models that have been implemented in other
The research concludes that the government must initiate a
test-pilot program to examine whether early detection and treatment do, in fact,
reduce pension expenses.
Welfare and Social Services Minister Isaac
Herzog, who read the report, said he believes the study will serve as an
important tool to decrease poverty and prevent job loss of thousands of people.
“It can serve as an important tool in planning the national economy and social
security. I instructed the rehabilitation department in my office to understand
the issue thoroughly and transfer my recommendations for action.”
global “Fit For Work?” project was made possible by an unconditional
grant from the Abbott pharmaceutical company, which has a branch in
“The company is deeply committed to its patients all over the
world, which is why, upon our request, it agreed to include Israel in
project,” said Tammy Altarac, general-manager of Abbott Pharma
“Now, for the first time, research-based data is available to
professional bodies and decision-makers, which we hope will assist them
aiding the patient community.”